Table 1 Incidence rates and reduction of Babesia canis transmission risk following fluralaner treatment
Country | Study group | Incidence rate [%] | P-valuea | Reduction [%] |
|---|---|---|---|---|
Albania | Fluralaner-treated (n = 23) | 0 (0.0) | ||
Untreated (n = 24) | 0 (0.0) | |||
France | Fluralaner-treated(n = 22) | 0 (0.0) | ||
Untreated (n = 23) | 0 (0.0) | |||
Hungary | Fluralaner-treated (n = 20) | 0 (0.0) | 0.0236 | 100.0 |
Untreated (n = 20) | 5 (25.0) | – | – | |
Overall | Fluralaner-treated (n = 65) | 0 (0.0) | 0.0312 | 100.0 |
Untreated (n = 67) | 5 (7.5%) | – | – |